Antiviral Favipiravir Successfully Treats Lassa Virus in Guinea Pigs

Tuesday, October 13, 2015

Favipiravir, an investigational antiviral drug currently being tested in West Africa as a treatment for Ebola virus disease, effectively treated Lassa virus infection in guinea pigs, according to a new study from National Institutes of Health (NIH) scientists and colleagues.